1. ,Thailand
2. ,Olsztyn,Poland
3. ,Poznan,Poland
扫 描 看 全 文
Somporn Chantra, Pinyada Hathaisaard, Andrzej Grzybowski, et al. Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital. [J]. AOPR 2(1):100046(2022)
Somporn Chantra, Pinyada Hathaisaard, Andrzej Grzybowski, et al. Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital. [J]. AOPR 2(1):100046(2022) DOI: 10.1016/j.aopr.2022.100046.
Background,It is possible that preservative-free eye drops can be contaminated. The aim of this study was to assess the incidence of microbial contamination of preservative-free hospital-prepared anti-infective eye drops and investigate factors that contribute to contamination. This finding may help to raise awareness of this problem to medical healthcare staff and patients in order to prevent the transmission of microorganisms from eye drops to the patients through treatment of pre-existing eye diseases.,Methods,Two hundred and ninety-five eye drop bottles were collected from patients attending Rajavithi Hospital Ophthalmologic outpatient and inpatient department, including both those used by patients at home and those administered in the hospital by medical staff. Samples were taken from the tips of droppers and bottles, and the residual fluid inside the bottles was then cultivated onto different culture plates. The culture results were identified and analyzed according to various factors related to both individual users and the bottles.,Results,Seven different types of eye drops were collected and 71 (24.06%) of the 295 bottles were contaminated. Vancomycin eye drops were the most contaminated. Twenty-six different types of pathogens were identified, most frequently mold (42.98%), and the amount of contamination was higher in tips than in residual fluid inside the bottle. There was no statistically significant difference in contamination between patients used eye drops collected in outpatient units (32.14%) and medical staff used eye drops collected in inpatient settings (23.22%). The only factor that was statistically significant was the number of eye drops used per person. We found that samples from patients who used only up to 2 eye drops suffered contamination (42.8%) more than those from their counterparts who used at least 3 (22.18%),P, = 0.02.,Conclusions,Of these preservative-free hospital preparations anti-infective eye drops, 24.06% were contaminated. The number of eye drops used per person was statistically significant in triggering contamination. There is a possibility of number of eyedrops use person may trigger contamination.
Background,It is possible that preservative-free eye drops can be contaminated. The aim of this study was to assess the incidence of microbial contamination of preservative-free hospital-prepared anti-infective eye drops and investigate factors that contribute to contamination. This finding may help to raise awareness of this problem to medical healthcare staff and patients in order to prevent the transmission of microorganisms from eye drops to the patients through treatment of pre-existing eye diseases.,Methods,Two hundred and ninety-five eye drop bottles were collected from patients attending Rajavithi Hospital Ophthalmologic outpatient and inpatient department, including both those used by patients at home and those administered in the hospital by medical staff. Samples were taken from the tips of droppers and bottles, and the residual fluid inside the bottles was then cultivated onto different culture plates. The culture results were identified and analyzed according to various factors related to both individual users and the bottles.,Results,Seven different types of eye drops were collected and 71 (24.06%) of the 295 bottles were contaminated. Vancomycin eye drops were the most contaminated. Twenty-six different types of pathogens were identified, most frequently mold (42.98%), and the amount of contamination was higher in tips than in residual fluid inside the bottle. There was no statistically significant difference in contamination between patients used eye drops collected in outpatient units (32.14%) and medical staff used eye drops collected in inpatient settings (23.22%). The only factor that was statistically significant was the number of eye drops used per person. We found that samples from patients who used only up to 2 eye drops suffered contamination (42.8%) more than those from their counterparts who used at least 3 (22.18%),P, = 0.02.,Conclusions,Of these preservative-free hospital preparations anti-infective eye drops, 24.06% were contaminated. The number of eye drops used per person was statistically significant in triggering contamination. There is a possibility of number of eyedrops use person may trigger contamination.
Microbial contaminationMultiple-dose eye dropsAnti-infective eye dropsPreservative-freeHospital ophthalmic preparation
1 A. Saisyo, R. Shimono, S. Oie, et al.The risk of microbial contamination in multiple-dose preservative-free ophthalmic preparations Biol Pharm Bull, 40 (2017), pp. 182-186, 10.1248/bpb.b16-00688
2 M.M. Nentwich, K.H.M. Kollmann, J. Meshack, et al.Microbial contamination of multi-use ophthalmic solutions in Kenya Br J Ophthalmol, 91 (2007), pp. 1265-1268, 10.1136/bjo.2007.116897
3 P. Bachewar N, D. Deshmukh, S.R. Choudhari, et al.Evaluation of used eye drop containers for microbial contamination in outpatient department of tertiary care teaching hospital Int J Basic Clin Pharmacol, 7 (2018), p. 895, 10.18203/2319-2003.ijbcp20181631
4 M.Q. Rahman, D. Tejwani, J.A. Wilson, et al.Microbial contamination of preservative free eye drops in multiple application containers Br J Ophthalmol, 90 (2006), pp. 139-141, 10.1136/bjo.2005.078386
5 B. Teuchner, J. Wagner, N.E. Bechrakis, et al.Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital Medicine (United States), 94 (2015), p. e583, 10.1097/MD.0000000000000583
6 O. Geyer, E.J. Bottone, S.M. Podos, et al.Microbial contamination of medications used to treat glaucoma Br J Ophthalmol, 79 (1995), pp. 376-379, 10.1136/bjo.79.4.376
7 R.A. Razooki, E.N. Saeed, H.I.O. Al-Deem Microbial Contamination of Eye Drops in Out Patient in Iraq #, vol. 20 (2011)
8 G. Høvding, H. SjursenBacterial contamination OF drops and dropper tips OF IN-use multidose eye drop bottles Acta Ophthalmol, 60 (1982), pp. 213-222, 10.1111/j.1755-3768.1982.tb08375.x
9 S. Kyei, R. Mensah, G. Kwakye-Nuako, et al.Microbial contamination of topical therapeutic ophthalmic medications in Cape Coast Metropolis, Ghana Niger J Ophthalmol, 27 (2019), p. 56, 10.4103/njo.njo_38_18
10 M. Feghhi, A.Z. Mahmoudabadi, M. MehdinejadEvaluation of fungal and bacterial contaminations of patient-used ocular drops Med Mycol, 46 (2008), pp. 17-21, 10.1080/13693780701487979
11 J.L. Ford, M.W. Brown, P.B. HuntA note ON the contamination OF eye-drops following use BY hospital out-patients J Clin Pharm Therapeut, 10 (1985), pp. 203-209, 10.1111/j.1365-2710.1985.tb01134.x
12 <797> Pharmaceutical Compounding-Sterile Preparations Type of Posting Revision Bulletin Posting Date 2019.
13 USP Compounding Standards and Beyond-Use Dates (BUDs) 2019.
14 A. Bizzini, C. Durussel, J. Bille, et al.Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory J Clin Microbiol, 48 (2010), pp. 1549-1554, 10.1128/JCM.01794-09
15 O. BaderMALDI-TOF-MS-based species identification and typing approaches in medical mycology Proteomics, 13 (2013), pp. 788-799, 10.1002/PMIC.201200468
16 M.S. Kim, C.Y. Choi, J.M. Kim, et al.Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers Br J Ophthalmol, 92 (2008), pp. 1518-1521, 10.1136/bjo.2008.144469
17 H.D. Perry, E.D. DonnenfeldIssues in the use of preservative-free topicals Manag Care, 12 (2003), pp. 39-41
18 J.D. Stevens, M.M. MathesonSurvey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing Br J Ophthalmol, 76 (1992), pp. 36-38, 10.1136/bjo.76.1.36
19 L. Tamrat, Y. Gelaw, G. Beyene, et al.Microbial contamination and antimicrobial resistance in use of ophthalmic solutions at the department of ophthalmology, Jimma University Specialized hospital, Southwest Ethiopia Can J Infect Dis Med Microbiol, 2019 (2019), 10.1155/2019/5372530
20 O. Thanathanee, W. Phanphruk, O. Anutarapongpan, et al.Contamination risk of 100% autologous serum eye drops in management of ocular surface diseases Cornea, 32 (2013), pp. 1116-1119, 10.1097/ICO.0b013e3182910036
21 B.A. Schlech, S. Sutton, R.A. Rosenthal, et al.Antimicrobial preservative effectiveness of VIGAMOX Invest Ophthalmol Vis Sci, 45 (2004), p. 4913 4913
22 R.J. MacK, S. Shott, S. Schatz, et al.Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis J Ocul Pharmacol Therapeut, 25 (2009), pp. 279-283, 10.1089/JOP.2008.0047
23 Normal Flora - PubMed n (2021) d. https://pubmed.ncbi.nlm.nih.gov/21413249/, Accessed 30th Jan 2021
24 Todars Online Textbook of Bacteriology (2021) pdf | Bacteria | Eukaryotes n.d https://www.scribd.com/document/374847410/Todars-Online-Textbook-of-Bacteriology-pdf, Accessed 30th Jan 2021
25 A. Grzybowski, P. Brona, S.J. KimMicrobial flora and resistance in ophthalmology: a review Graefes Arch Clin Exp Ophthalmol, 255 (2017), pp. 851-862, 10.1007/S00417-017-3608-Y
26 A. Malmin, H. Syre, A. Ushakova, et al.Twenty years of endophthalmitis: incidence, aetiology and clinical outcome Acta Ophthalmol, 99 (2021), 10.1111/AOS.14511 e62–9
27 J.A. An, O. Kasner, D.A. Samek, et al.Evaluation of eyedrop administration by inexperienced patients after cataract surgery J Cataract Refract Surg, 40 (2014), pp. 1857-1861, 10.1016/j.jcrs.2014.02.037
28 Bacterial Keratitis PPP - 2018 - American Academy of Ophthalmology n (2021) d. https://www.aao.org/preferred-practice-pattern/bacterial-keratitis-ppp-2018, Accessed 27th Dec 2021
29 C.L. Moser, B.K. MeyerComparison of compendial antimicrobial effectiveness tests: a review AAPS PharmSciTech, 12 (2011), p. 222, 10.1208/S12249-010-9575-9
30 T. Daehn, A. Schneider, J. Knobloch, et al.Contamination of multi dose eyedrops in the intra and perioperative context Sci Rep, 11 (2021), 10.1038/S41598-021-99892-8
31 S. Kyei, D. France, K. AsieduMicrobial contamination of multiple-use bottles of fluorescein ophthalmic solution Clin Exp Optom, 102 (2019), pp. 30-34, 10.1111/CXO.12821/SUPPL_FILE/TCEO_A_12124399_SM0002.TIF
32 S. Kyei, E. Appiah, E.A. Ayerakwa, et al.Microbial safety implications of in-use topical diagnostic ophthalmic medications in eye clinics in Ghana J Opt, 12 (2019), pp. 263-271, 10.1016/J.OPTOM.2019.02.002
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution